• Eurofins Expands Its Leading Global Cosmetic Testing Footprint with the Acquisition of Clinical Research Laboratories in North America

    • September 5, 2018
    • Posted By : admin
    • 0 Comment

    Eurofins Scientific (EUFI.PA), a global leader in bioanalytical testing, announces that it has successfully closed the acquisition of Clinical Research Laboratories LLC (“CRL”), one of the leaders in the Cosmetic Testing market in North America.

    Established in 1992, and in continuous expansion ever since, CRL has established a significant reputation for excellence in clinical studies, safety and efficacy testing to the cosmetic, beauty products, personal care, and pharmaceutical industries in North America. CRL provides testing services to a large number of international corporations.

    Headquartered in central New Jersey and with subsidiaries in North Carolina and Texas, the company employs over 100 highly skilled staff and generated revenues of over US$ 12m in 2017.

    As a result of this acquisition, Eurofins now has a global cosmetic and personal care testing footprint and is becoming the leading company serving the cosmetics and personal care industries worldwide. Eurofins can now offer its clients the most comprehensive cosmetics testing portfolio from its global network of over 25 state-of-the-art personal care products and cosmetics testing laboratories in Europe, Asia, Australia and now the United States.

    Comment from Dr. Gilles Martin, Eurofins CEO: “We are very pleased to welcome CRL and its teams to the Eurofins Group. This acquisition is a perfect geographic complement to our existing footprint in the cosmetic and personal care products testing field, and provides Eurofins with a global leadership position in the cosmetic testing market.”


You Might Also Like

No comments found



error: Content is protected !!